Funding and support provided by

APOS PSYCHOSOCIAL
POCKET GUIDE

A quick reference resource for psychosocial professionals

The information contained in this guide does not constitute medical advice and is not intended to replace a healthcare provider’s independent medical judgment regarding the treatment or management of individual patients.

Table of Contents

Home 5 References

References & Links

 

Distress Screening & Assessment

 

  1. References

    1. Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. Journal of Clinical Oncology. 2013; 31(6):782-793.
    2. Zebrack B, Kayser K, Bybee D, et al. Psychosocial distress screening and medical service utilization: A report from the Association of Oncology Social Work Project to Assure Quality Cancer Care (APAQCC). Journal of the National Comprehensive Cancer Network. 2017; 15:903-912.
    3. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelinesâ) for Distress Management V.2.2024. ã National Comprehensive Cancer Network, Inc. 2024. All rights reserved. Accessed April 3,2024. To view most recent and complete version of the guideline, go online to NCCN.org.
    4. QOPI Certification Practice Standards 2020. https://society.asco.org/sites/new-www.asco.org/files/content-files/practice-patients/documents/2020-QOPI-QCP-Standards.pdf. Accessed April 3, 2024
    5. Commission on Cancer: Optimal Resources for Cancer Care: Ensuring Patient-Centered Care. Commission on Cancer. Chicago, IL. American College of Surgeons, 2020. https://www.facs.org/quality-programs/cancer/coc/standards/2020. Accessed May 19, 2022.
    1. Pirl W, Fann J, Greer J, et al. Recommendations for the implementation of distress screening programs in cancer centers: Report from the American Psychosocial Oncology Society, Association of Oncology Social Work, and Oncology Nursing Society Joint Task Force. Cancer. 2014; 120(19): 2946-2954.
    2. Deshields, TL, Wells-Di Gregorio, S, Flowers, SR, Irwin, KE, Nipp, R, Padgett, L, Zebrack, B. Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work. CA Cancer J Clin. 2021.
    3. PROMIS (Patient-Reported Outcomes Measurement Information System. Available from URL: https://www.healthmeasures.net/explore-measurement-systems/promis.
    4. Hui D, E B. The Edmonton Symptom Assessment System 25 years later: past, present and future developments. Journal of Pain and Symptom Management. 2017;53: 630-643.
    5. PHQ family of measures, including the GAD-7. Available from URL: https://www.phqscreeners.com.
    6. Snaith RP, AS Z. Hospital Anxiety and Depression Scale. Available from URL: https://eprovide.mapi-trust.org/instruments/hospital-anxiety-and-depression-scale.
    7. Donovan, K. A., Handzo, G., Corbett, C., Vanderlan, J., Brewer, B. W., & Ahmed, K. NCCN Distress Thermometer Problem List Update. Journal of the National Comprehensive Cancer Network. 2022; 20: 96-98.
    8. Exline JJ, Pargament KI, Grubbs JB, AM Y. The Religious and Spiritual Struggles Scale: development and initial validation. Psychology of Religion and Spirituality. 2014;6: 208-222.
    9. Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. Journal of Clinical Oncology. 2007; 25:4670-81.
    10. Adapted with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Distress Management V.2.2024. © 2024 National Comprehensive Cancer Network, Inc. All rights reserved. The NCCN Guidelines® and illustrations herein may not be reproduced in any form for any purpose without the express written permission of NCCN. To view the most recent and complete version of the NCCN Guidelines, go online to NCCN.org. The NCCN Guidelines are a work in progress that may be refined as often as new significant data becomes available.
    11. Donovan, K. A., Grassi, L., Deshields, T. L., et al. (2020). Advancing the science of distress screening and management in cancer care. Epidemiology and Psychiatric Sciences, 29.
    12. AACR Cancer Disparities Progress Report 2020. Philadelphia: American Association for Cancer Research;2020.
    13. Kagawa‐Singer M, Valdez Dadia A, Yu MC, Surbone A. Cancer, culture, and health disparities: Time to chart a new course? CA Cancer J Clin. 2010;60(1):12-39.
    14. Kleinman A, Eisenberg L, Good B. Culture, illness, and care: Clinical lessons from anthropologic and cross-cultural research. Annals of Internal Medicine. 1978;88(2):251-258.
    15. Ashing KT, Loscalzo M, Burhansstipanov L, Huei-yu Wang J, Napoles A. Attending to distress as part of quality, comprehensive cancer care: Gaps and diversity considerations. Expert Rev Qual Life Cancer Care. 2017;1(4):257-259.
Psychiatric Emergencies

 

  1. Rasimas, J. J., & Sinclair, C. M. (2017). Assessment and management of toxidromes in the critical care unit. Critical care clinics, 33(3), 521-541.
  2. Stone, J. B., & DeAngelis, L. M. (2016). Cancer-treatment-induced neurotoxicity—focus on newer treatments. Nature reviews Clinical oncology, 13(2), 92-105.
  3. Perry, P. J., & Wilborn, C. A. (2012). Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Ann Clin Psychiatry, 24(2), 155-162.
  4. Rasmussen, S. A., Mazurek, M. F., & Rosebush, P. I. (2016). Catatonia: our current understanding of its diagnosis, treatment and pathophysiology. World journal of psychiatry, 6(4), 391.
  5. Schirrmacher, V. (2019). From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment. International journal of oncology, 54(2), 407-419.
  6. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
  7. Trzepacz P.T., Meagher D.J., Leonard M. (2011). Delirium. In J.L. Levenson (Ed.), Textbook of Psychosomatic Medicine (2nd ed., pp. 71-114).
  8. Breitbart W.S., Alicia Y. (2010). Delirium. In J.C. Holland, W.S. Breitbart, P.B. Jacobsen, M.S. Lederberg, M.J. Loscalzo, R. McCorkle (Eds.), Psycho-Oncology (2nd ed., pp. 332-339).
  9. Breitbart, W. S., & Alicia, Y. (Apr 10 2012). Evidence-based treatment of delirium in patients with cancer. J clin Oncol. 30(11),1206-1214.
  10. Roth AJ, Levenson JA. (2015). Psychiatric Emergencies. In J. C. Holland, M. Golant, D. B. Greenberg, M.K. Hughes, J.A. Levenson, M.J. Loscalzo, W.F. Pirl (Eds.), Psycho-Oncology: A Quick Reference on the Psychosocial Dimensions of Cancer Symptom Management (2nd ed., pp. 37-44).
  11.  https://afsp.org/suicide-statistics/
  12. Zaorsky, N.G., Zhang, Y., Tuanquin, L. et al. Suicide among cancer patients. Nat Commun 10, 207 (2019). https://doi.org/10.1038/s41467-018-08170-1
  13. McFarland DC, Walsh L, Napolitano S, Morita J, Jaiswal R. Suicide in Patients With Cancer: Identifying the Risk Factors. 2019;7.
  14. D’Anci KE, Uhl S, Giradi G, Martin C. Treatments for the Prevention and Management of Suicide: A Systematic Review. Ann Intern Med. 2019 Sep 3;171(5):334.
  15. Hopko D. R. Funderburk J. S. Shorey R. C. McIndoo C. C. Ryba M. M. File A. A., et al. Vitulano M. (2013). Behavioral activation and problem-solving therapy for depressed breast cancer patients: Preliminary support for decreased suicidal ideation. Behavior Modification, 37(6), 747–767.
  16. https://www.nimh.nih.gov/research/research-conducted-at-nimh/asq-toolkit-materials
Psychological Disorders, Psychosocial Concerns, & Evidence-Based Interventions

 

  1. Greer JA, Solis JM, Temel JS, Lennes IT, Prigerson HG, Maciejewski PK, Pirl WF. Anxiety disorders in long-term survivors of adult cancers. Psychosomatics. 2011 Sep 1;52(5):417-23.
  2. Bolton JM, Cox BJ, Afifi TO, Enns MW, Bienvenu OJ, Sareen J. Anxiety disorders and risk for suicide attempts: findings from the Baltimore Epidemiologic Catchment area follow‐up study. Depression and anxiety. 2008 Jun 1;25(6):477-81.
  3. Hofmann SG, Hinton DE. Cross-cultural aspects of anxiety disorders. Current psychiatry reports. 2014 Jun;16(6):1-5.
  4. Samuel CA, Mbah OM, Elkins W, Pinheiro LC, Szymeczek MA, Padilla N, Walker JS, Corbie-Smith G. Calidad de Vida: a systematic review of quality of life in Latino cancer survivors in the USA. Quality of Life Research. 2020 Oct;29(10):2615-30.
  5. Glynne-Jones R, Chait I, Thomas SF. When and how to discharge cancer survivors in long term remission from follow-up: the effectiveness of a contract. Clinical Oncology. 1997 Jan 1;9(1):25-9.
  6. Brown TA, Barlow DH. Anxiety and related disorders interview schedule for DSM-5 (ADIS-5)-adult and lifetime version: Clinician manual. Oxford University Press; 2014.
  7. First MB, Williams JB, Karg RS, Spitzer RL. Structured clinical interview for DSM-5—Research version. Arlington, VA: American Psychiatric Association. 2015.
  8. Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults. CA: a cancer journal for clinicians. 2015;65(2):123-138.
  9. Országhová Z, Mego M, Chovanec M. Long-Term Cognitive Dysfunction in Cancer Survivors. Frontiers in Molecular Biosciences. 2021;8
  10. Wefel J, Vardy, J, Ahles, T, Schagen, Sanne B. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. The Lancet Oncology. 2011;12(7):703-708.
  11. Rivera Mindt, M., Byrd, D., Saez, P., & Manly, J. Increasing culturally competent neuropsychological services for ethnic minority populations: A call to action. The Clinical Neuropsychologist, 2010; 24(3), 429-453.
  12. Von Ah D, Crouch A. Cognitive rehabilitation for cognitive dysfunction after cancer and cancer treatment: implications for nursing practice. Elsevier; 2020:150977.
  13. Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA: a cancer journal for clinicians. 2019;69(5):363-385.
  14. Endicott J. Measurement of depression in patients with cancer. Cancer. 1984 May 15;53(10 Suppl):2243-9. doi:10.1002/cncr.1984.53.s10.2243.PMID:6704912. https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.1984.53.s10.2243
  15. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-174. doi:10.1016/S1470-2045(11)70002-X  https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.900.840&rep=rep1&type=pdf
  16. Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012;366(14):1310-1318. doi:10.1056/NEJMoa1110307 https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.1067.6992&rep=rep1&type=pdf
  17. Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23(2):121-130. doi:10.1002/pon.3409 https://doi:10.1002/pon.3409
  18. Wakefield CE, Butow PN, Aaronson NA, et al. Patient-reported depression measures in cancer: a meta-review. Lancet Psychiatry. 2015;2(7):635-647. doi:10.1016/S2215-0366(15)00168-6 https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(15)00168-6/fulltext
  19. Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605-1619. doi:10.1200/JCO.2013.52.4611 https://dx.doi.org/10.1200%2FJCO.2013.52.4611 https://www.journalslibrary.nihr.ac.uk/hta/hta23190#/abstract
  20. Li M, Kennedy EB, Byrne N, et al. Management of Depression in Patients With Cancer: A Clinical Practice Guideline [published correction appears in J Oncol Pract. 2017 Feb;13(2):144]. J Oncol Pract. 2016;12(8):747-756. doi:10.1200/JOP.2016.011072 https://doi.org/10.1200/JOP.2016.011072
  21. Data Supplement: https://ascopubs.org/doi/suppl/10.1200/JOP.2016.011072/suppl_file/DS_2016.011072.pdf
  22. Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Tookman A, Mannix K, Gola A, Davis S, Wood J, Jones L. Manualised cog nitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT. Health Technol Assess. 2019 May;23(19):1-106. doi: 10.3310/hta23190. PMID: 31097078; PMCID: PMC6545499. https://doi.org/10.3310/hta23190
  23. Li M, Kennedy EB, Byrne N, et al. Systematic review and meta-analysis of collaborative care interventions for depression in patients with cancer. Psychooncology. 2017;26(5):573-587. doi:10.1002/pon.4286 https://doi.org/10.1002/pon.4286
  24. Schulz-Quach C, Li M, Miller K, Rodin G. Depressive disorders in cancer. In: Breitbart WS, Butow PN, Jacobsen PB, Lam WWT, Lazenby M, Loscalzo MJ, eds. Psycho-Oncology. 4th ed. Oxford University Press; 2021:320-328.
  25. Foronda C, Baptiste DL, Reinholdt MM, Ousman K. Cultural Humility: A Concept Analysis. J Transcult Nurs. 2016 May;27(3):210-7. doi: 10.1177/1043659615592677. Epub 2015 Jun 28. PMID: 26122618. https://doi.org/10.1177/1043659615592677
  26. Mulick A, Walker J, Puntis S, Burke K, Symeonides S, Gourley C, Wanat M, Frost C, Sharpe M. Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials. Lancet Psychiatry. 2018 Apr;5(4):321-326. doi: 10.1016/S2215-0366(18)30061-0. Epub 2018 Mar 12. PMID: 29544711. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30061-0/fulltext
  27. McNally G and Sica A. Addiction in patients with cancer: Challenges and Opportunities. J Adv Pract Oncol. 2021 Sep; 12(7): 740–746.
  28. Kirsh KL, Passik SD. The Interface Between Pain and Drug Abuse and the Evolution of Strategies to Optimize Pain management while Minimizing Drug Abuse. Experimental and Clinical Psychopharmacology 2008, 16 (5): 400-404.
  29. Lundberg J, Passik SD. Alcohol and Cancer: A review for psycho-oncologists. Psycho-oncology. 1997; 6 (4):253-266.
  30. Passik SD, Portenoy RK, Ricketts PL. Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. Oncology, 1998; 12(4):517-521.
  31. Passik SD, Portenoy RK, Ricketts PL. Substance abuse issues in cancer patients. Part 2: Evaluation and treatment. Oncology, 1998; 12(5):729-736.
  32. NCCN and ASCO guidelines/algorithm
  33. ASCO algorithm https://www.asco.org/sites/new-www.asco.org/files/content-files/practice-and-guidelines/documents/fatigue-algorithm.pdf
  34. Cancercare.org   https://www.cancercare.org/tagged/fatigue
  35. Wang F, Luo D, Fu L, Zhang H, Wu S, Zhang M, Zhou H, Sun T, Chen X (2017) The efficacy of couple-based interventions on health-related quality of life in cancer patients and their spouses: a meta-analysis of 12 randomized controlled trials. Cancer Nurs 40: 39-47. https://doi.org/10.1097/NCC.0000000000000356
  36. WHO . Redefining sexual health for benefits throughout life. 2.11.22, WHO.org accessed 5.5.22.
  37. Kissane D, Bultz B Butow P, Bylund C, Noble S, Wilkinson S, (2017Oxford textbook of communication in oncology and palliative care. 2nd edn. Oxford: Oxford University Press:Carter J, Jacchetti C, Andersen BL, et al.(2018) Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. J Clin Oncol;36:492-511.
  38. Denlinger CS, Baker KS, Baxi S, et al. (2017) Survivorship Version 2.2017. J Natl Compr Cancer Netw:15:1140-63
  39. Leiblum S, Symonds T, Moore J, Soni P, Steinberg S, Sisson M. (2006) A methodology study to develop and validate a screener for hypoactive sexual desire disorder in postmenopausal women. J Sex Med;3:455-464.
  40. Annon JS (1976). The PLISSIT Model: A proposed conceptual scheme for the behavioral treatment of sexual problems. J Sex Edu and TherMNB, 2, 1-15.
  41. Pratt-Chapman M, Alpert A, Castillo D. (2021) Health outcomes of sexual and gender minorities after cancer: a systematic review. Systematic Reviews:10:183https//doi.org/10.1186/s13643-021-01707-4
  42. Byers, ES & MacNeil s. (2006). Further validation of the interpersonal exchange model of sexual satisfaction. J Sex & Marital Ther, 32, 53-69.
  43. Rosen R, Cappelleri J, Smith M, Lipsky J, & Pena B. (1999).Development ad evaluztion of an abridged 5-item version of the International index of Erectile Function as a diagnostic tool for erectile dysfunction. Intl J Impo Res,,11, 219-326.
  44. Taylor J, Rosen R, & Leiblum S. (1994). Self-report assessment of female sexual function: Psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arc Sex Beh, 23, 627-643.
  45. Donovan K, Gonzalez B, Nelson A, Fishman M, Zachariah B, Jacobsen P. (2018). Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison. Psycho-onc, 27:316-324. DOI: 10-1002/pon.4463
  46. Wittmann D.  (2016). Emotional and sexual health in cancer: partner and relationship issues. J Supp and Pall Care.
  47. National Cancer Institute, Financial Toxicity and Cancer Treatment (PDQ®)–Health Professional Version: https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-hp-pdq
  48. Zafar SY. Financial Toxicity of Cancer Care: It’s Time to Intervene. J Natl Cancer Inst. May 2016;108(5)doi:10.1093/jnci/djv370
  49. Bradley CJ, Yabroff KR, Shih YT. A Coordinated Policy Approach to Address Medical Financial Toxicity. JAMA Oncol. Dec 1 2021;7(12):1761-1762. doi:10.1001/jamaoncol.2021.3606
  50. COST FACIT Questionnaire: https://www.facit.org/measures/FACIT-COST
  51. ASCO Choosing Wisely: https://www.choosingwisely.org/societies/american-society-of-clinical-oncology/
  52. National Alliance for Caregiving in Collaboration with AARP. (2020). Cancer Caregiving in the U.S.https://www.caregiving.org/caregiving-in-the-us-2020/
  53. National Alliance for Caregiving in Collaboration with AARP. (2016). Cancer caregiving in the U.S.: An intense, episodic, and challenging care experience. https://www.caregiving.org/wp-content/uploads/2020/05/CancerCaregivingReport_FINAL_June-17-2016.pdf
  54. Cancer Caregivers. (2019). (A. Applebaum, Ed.). Oxford University Press.
  55. Reinhard, S. C., Young, H. M., Ryan, E., & Choula, R. B. (2019). The CARE Act Implementation: Progress and Promise. AARP Public Policy Institute. https://www.aarp.org/content/dam/aarp/ppi/2019/03/the-care-act-implementation-progress-and-promise.pdf
  56. Applebaum, A. J., Kent, E. E., & Lichtenthal, W. G. (2021). Documentation of Caregivers as a Standard of Care. Journal of Clinical Oncolcolo
  57. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition. Arlington: American Psychiatric Publishing, 2013.
  58. Aoun SM, Breen LJ, Howting DA, et al. Who needs bereavement support? A population based survey of bereavement risk and support need. PLoS One 2015;10:e0121101.
  59. Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res 1967;11:213-8.
  60. Lobb EA, Kristjanson LJ, Aoun SM, et al. Predictors of complicated grief: A systematic review of empirical studies. Death Stud 2010;34:673-98.
  61. Maciejewski PK, Zhang B, Block SD, Prigerson HG. An empirical examination of the stage theory of grief. JAMA, 2007;297(7):716-723.
  62. Morris SE, Anderson CM, Tarquini SJ, Block SD. A standardized approach to bereavement risk-screening: a quality improvement project. J Psychosoc Oncol. 2020 Jul-Aug;38(4):406-417. doi: 10.1080/07347332.2019.1703065. Epub 2019 Dec 29. PMID: 31885337.
  63. Morris SE. Block SD. Grief and bereavement. In: Grassi L, Riba M. editors. Clinical Psycho-oncology: An international perspective. Oxford: Wiley-Blackwell, 2012:271-80.
  64. Morris SE, Block SD. Adding value to palliative care services: The development of an institutional bereavement program. J Palliat Med 2015;18:915-22.
  65. Morris S, Fletcher K, Goldstein R. The grief of parents after the death of a young child. J Clin Psychol Med Settings 2019;26:321-38.
  66. Morris SE, Paterson N, Mendu ML. Grieving and hospital-based bereavement care during the COVID-19 pandemic. J Hosp Med, 2020 Nov;15(11):699-701. doi: 10.12788/jhm.3503. PMID: 33147131.
  67. National Consensus Project for Quality Palliative Care. Clinical Practice Guidelines for Quality Palliative Care, 4th edition. Richmond, VA: National Coalition for Hospice and Palliative Care; 2018. https://www. nationalcoalitionhpc.org/ncp.
  68. Prigerson, HG, Horowitz, MJ, Jacobs, SC, Parkes, CM, Aslan M, et al. (2009) Prolonged Grief Disorder: Psychometric Validation of Criteria Proposed for DSM-V and ICD-11. PLoS Med 6(8): e1000121. doi:10.1371/journal.pmed.1000121
  69. Prigerson HG, Shear MK, Reynolds III CF. Prolonged Grief Disorder Diagnostic Criteria— Helping those with maladaptive grief responses. JAMA Psychiatry, Feb 2, 2022.
  70. Probst DR, Gustin JL, Goodman LF, Lorenz A, Wells-Di Gregorio SM. ICU versus Non-ICU Hospital Death: Family Member Complicated Grief, Posttraumatic Stress, and Depressive Symptoms. J Palliat Med. 2016 Apr;19(4):387-93. doi: 10.1089/jpm.2015.0120. Epub 2016 Feb 1. PMID: 26828564.
  71. Stroebe M, Schut H, Stroebe W. Health outcomes of bereavement. Lancet 2007;370:1960-73.
  72. Pistrang N, Barker C. The partner relationship in psychological response to breast cancer. Soc Sci Med. 1995;40:789-797.
  73. Banthia R, Malcarne VL, Varni JW, Ko CM, Sadler GR, Greenbergs HL. The effects of dyadic strength and coping styles on psychological distress in couples faced with prostate cancer. J Behav Med. Feb 2003;26(1):31-52.
  74. Baider L, Kaufman B, Peretz T, Manor O, Ever-Hadani P, Kaplan De-Nour A. Mutuality of fate: adaptation and psychological distress in cancer patients and their partners. In: Baider L, Cooper C, Kaplan De-Nour A, eds. Cancer in the Family. Wiley; 1996:173-186.
  75. Ell K, Nishimoto R, Mantell J, Hamovitch M. Longitudinal analysis of psychological adaptation among family members of patients with cancer. J Psychosom Res. 1988;32:429.
  76. Karraker A, Latham K. In sickness and in health? Physical illness as a risk factor for marital dissolution in later life. J Health Soc Behav. 2015;56(3):420-435.
  77. Syse A, Kravdal Ø. Does cancer affect the divorce rate? Demographic Research. 2007;16:469-492.
  78. Carlson RH. Study: women with brain tumors have 10 times rate of divorce as men with brain tumors. Oncology Times. 2001;23(8):63.
  79. Langer SL, Jean CY, Syrjala KL, Schoemans H, Mukherjee A, Lee SJ. Prevalence of and Factors Associated with Marital Distress among Hematopoietic Cell Transplantation Survivors: Results from a Large Cross-Sectional Study. Transplantation and Cellular Therapy. 2022;
  80. Nalbant B, Karger A, Zimmermann T. Cancer and Relationship Dissolution: Perspective of Partners of Cancer Patients. Frontiers in psychology. 2021;12
  81. Manne S, Badr H. Intimacy and relationship processes in couples’ psychosocial adaptation to cancer. Cancer. 2008;112(S11):2541-2555.
  82. Badr H, Acitelli LK, Carmack Taylor CL. Does talking about their relationship affect couples’ marital and psychological adjustment to lung cancer? J Cancer Surviv. 2008;2(1):53-64. 18648987.
  83. Badr H, Carmack Taylor CL. Effects of relational maintenance on psychological distress and dyadic adjustment among couples coping with lung cancer. Health Psychol. 2008;27(5):616-627. 18823188.
  84. Traa MJ, De Vries J, Bodenmann G, Den Oudsten BL. Dyadic coping and relationship functioning in couples coping with cancer: a systematic review. British Journal of Health Psychology. 2015;20(1):85-114.
  85. Hunsley J, Best M, Lefebvre M, Vito D. The seven item short form of the dyadic adjustment scale: Further evidence for the construct validity. The American Journal of Family Therapy. 2001;29(4):325-335.
  86. Badr H, Krebs P. A systematic review and meta-analysis of psychosocial interventions for couples coping with cancer. Psychooncology. 2013;22:1688-1704.
  87. Hu Y, Liu T, Li F. Association between dyadic interventions and outcomes in cancer patients: a meta-analysis. journal article. Support Care Cancer. March 01 2019;27(3):745-761. doi:10.1007/s00520-018-4556-8
  88. Corter, A.L., Broom, R., Porter, D., Harvey, V., & Findlay, M. (2018). Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer. Psycho-oncology, 27, 2096-2103. https://doi.org/10.1002/pon.4771
  89. DiMatteo, M. R., Haskard-Zolnierek, K. B., & Martin, L. R. (2011). Improving patient adherence: A three-factor model to guide practice. Health Psychology Review, 1-18.  https://www.researchgate.net/publication/233251626
  90. Dobie, S.A., Baldwin, L.M., Dominitz, J.A., Matthews, B., Billilngsley, K., & Barlow, W. (2006). Completion of therapy by Medicare patients with stage III colon cancer. Journal of the National Cancer Institute, 98(9), 610-619. https://doi.org/10.1093/jnci/djj159
  91. Hershman, D.L., Neugut, A.I., Moseley, A., Arnold, K.B., Gralow, J.R., Henry, N.L., Hillyer, G.C., Ramsey, S.D., & Unger, J.M. (2021). Patient-reported outcomes and long-term nonadherence to aromatase inhibitors. Journal of the National Cancer Institute, 113(8), 989-996. https://doi.org/10.1093/jnci/djab022
  92. Kalichman, S. C., Amaral, C. M., Swetzes, C., Jones, M., Macy, R., Kalichman, M. O., & Cherry, C. (2009). A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. Journal of the International Association of Physicians in AIDS Care, 8(6), 367–374. https://doi.org/10.1177/1545109709352884
  93. Lehmann, A., Aslani, P., Ahmed, R., Celio, J., Gauchet, A., Bedouch, P., Bugnon, O., Allenet, B., & Schneider, M.P. (2014). Assessing medication adherence: Options to consider. International Journal of Clinical Pharmacy, 36, 55-69. https://doi.org/10.1007/s11096-013-9865-x
  94. McHorney C. A. (2009). The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Current medical research and opinion, 25(1), 215–238. https://doi.org/10.1185/03007990802619425
  95. Stirratt, M. J., Dunbar-Jacob, J., Crane, H. M., Simoni, J. M., Czajkowski, S., Hilliard, M. E., Aikens, J. E., Hunter, C. M., Velligan, D. I., Huntley, K., Ogedegbe, G., Rand, C. S., Schron, E., & Nilsen, W. J. (2015). Self-report measures of medication adherence behavior: recommendations on optimal use. Translational Behavioral Medicine, 5(4), 470–482. https://doi.org/10.1007/s13142-015-0315-2
  96. Svarstad, B. L., Chewning, B. A., Sleath, B. L., & Claesson, C. (1999). The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient education and counseling, 37(2), 113–124. https://doi.org/10.1016/s0738-3991(98)00107-4
  97. Watson, C.H., Fish, L.J., Falkovic, M., Monuszko, K., Lorenzo, A., Havrilesky, L.J., Secord, A.A., & Davidson, B.A. (2020). Adherence to oral anticancer therapeutics in the gynecologic oncology population. Obstetrics & Gynecology, 136(6), 1145-1153. https://doi.org/10.1097/AOG.0000000000004170
  98. Smith TJ. The art of oncology: when the tumor is not the target- tell it like it is. Journal of clinical oncology, Vol 19. 3441-45. 2000
  99. Curtis JR, Wenrich MJ, Carline JD, et al. Understanding physicians’ skills at providing end of life care. Journal of General Internal Medicine. 16: 41-49. 2001
  100. Herth K. Fostering hope in terminally ill people. Journal of Advanced Nursing. 15. 1250-59. 1990
  101. Shockney L. Fulfilling Hope: Supporting the needs of patients with advanced cancers. Nova Science. NY. 2014
  102. Elwyn, G., Frosch, D., Thomson, R., Joseph-Williams, N., Lloyd, A., Kinnersley, P., … & Barry, M. (2012). Shared decision making: a model for clinical practice. Journal of general internal medicine, 27(10), 1361-1367.
  103. Childers, J. W., Back, A. L., Tulsky, J. A., & Arnold, R. M. (2017). REMAP: A framework for goals of care conversations. Journal of Oncology Practice, 13(10), e844-e850.
  104. Steinhauser, K. E., Clipp, E. C., McNeilly, M., Christakis, N. A., McIntyre, L. M., & Tulsky, J. A. (2000). In search of a good death: observations of patients, families, and providers. Annals of internal medicine, 132(10), 825–832. https://doi.org/10.7326/0003-4819-132-10-200005160-00011
  105. Singer PA, Martin DK, Kelner M. (1999) Quality of life care-patients’ perspectives. JAMA. Vol 181, No 2, 163-68.
  106. National Academies of Sciences, Engineering, and Medicine. Approaching Death: Improving Care at the End of Life. Washington, DC: The National Academies Press. https://doi.org/10.17226/5801.1997
  107. Yabroff K, Mandelblatt JS, Ingham J. The quality of medical care at the end of life in the USA existing barriers and examples of process and outcomes measures. Palliative Medicine. 18(3), 202-216. 2004.
  108. Peppercorn JM, Smith TJ, Helft PR, et al. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. Journal of Clinical Oncology. 29:755-60. 2011
Psychosocial Care Models and Professional Development

 

  1. Pirl W, Greer J, & Wells-Di Gregorio S, et al. Framework for planning the delivery of psychosocial oncology services: an American psychosocial oncology society task report. Psycho-Oncology. 2020; 29:982-1987.
  2. Fann J, Ell K, Sharpe M. Integrating psychosocial care into cancer services. J Clin Oncol. 2012; 30(11):1178–1186.
  3. Heath, B. Wise Romero, P, K. Reynolds. A standard framework for levels of integrated healthcare. Washington, DC: SAMHSA-HRSA Center for Integrated Health Solutions. 2013.
  4. Sharpe M, Walker J, Holm Hansen C, Martin P, Symeonides S, Gourley C, Wall L, Weller D, Murray G. 2014. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet 384(9948):1099-108.
  5. Li M, Kennedy EB, Byrne N, et al. Systematic review and meta-analysis of collaborative care interventions for depression in patients with cancer. Psycho-Oncology. 2017; 26(5):573-587
  6. Courtnage T, Bates NE, Armstrong AA, et al. Enhancing integrated psychosocial oncology through leveraging the oncology social worker’s role in collaborative care. Psycho-Oncology. 2020; 29:2084-2090.
  7. Oldham MA, Desan PH, Lee HB, Bourgeois JA, Shah SB, Hurley PJ, Sockalingam S; Council on Consultation-Liaison Psychiatry. Proactive Consultation-Liaison Psychiatry: American Psychiatric Association Resource Document. J Acad Consult Liaison Psychiatry. 2021 Mar-Apr;62(2):169-185.
  8. Ell K, Xie B, Kapetanovic S, et al. One-year follow-up of collaborative depression care for low-income, predominantly Hispanic patients with cancer. Psychiatr Serv. 2011; 62(2):162–170.
  9. Walker J, Hobbs H, Wanat M, et al. Implementing collaborative care for major depression in a cancer center: an observation study using mixed-methods. Gen Hosp Psychiatry. 2022; 76: 3-15.
  10. Walker, J., Magill, N., Rosenstein, D. L., Frost, C., & Sharpe, M. (2021). Suicidal thoughts in patients with cancer and comorbid major depression: findings from a depression screening program. Journal of the Academy of Consultation-Liaison Psychiatry.
  11. Simpson SA, et al. (2020). Updates in Consultation-Liaison Psychiatry: 2019. Psychosomatics, 61(5), 450-455.
  12. White VM, et al. (2021). Improving access to cancer information and supportive care services: A systematic review of mechanisms applied to link people with cancer to psychosocial supportive care services. Psycho‐Oncology, 30(10), 1603-1625.
  13. Keng, A., Stewart, D. E., & Sheehan, K. A. (2021). Neuropsychiatric Symptoms After Brain Tumor Resection in Children and Adolescents: A Scoping Review. Journal of the Academy of Consultation-Liaison Psychiatry.
  14. Fann JR, et al. (2012). Integrating psychosocial care into cancer services. Journal of Clinical Oncology, 30(11), 1178-1186.
  15. Sanchez-Reilly, S., Morrison, L. J., Carey, E., Bernacki, R., O’Neill, L., Kapo, J., … & Thomas, J. D. (2013). Caring for oneself to care for others: physicians and their self-care. The journal of supportive oncology, 11(2), 75.
  16. Taplin, S. H., Foster, M. K., & Shortell, S. M. (2013). Organizational leadership for building effective health care teams. The Annals of Family Medicine, 11(3), 279-281.
  17. Loscalzo, S., Clark, K., Bultz, B., & Kotwell, J. Building supportive care teams: working together and self care. In: Breitbart, W., Butow, P., Jacobsen, P., Lam, W., Lazenby, M., & Loscalzo, M. (Eds.). (2021). Psycho-oncology. Oxford University Press.
  18. Osseo-Asare, A., Balasuriya, L., Huot, S. J., Keene, D., Berg, D., Nunez-Smith, M., … & Boatright, D. (2018). Minority resident physicians’ views on the role of race/ethnicity in their training experiences in the workplace. JAMA network open, 1(5), e182723-e182723.
  19. https://org/?url=https%3A%2F%2Fnami.org%2FYour-Journey%2FFrontline-Professionals%2FHealth-Care-Professionals
  20. https://www.ptsd.va.gov/professional/treat/type/skills_psych_recovery_manual.asp